| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.66 | 5e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.58 | 0.0001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |